SRSF2 and myelodysplastic syndrome: In contrast, mutations in SRSF2 are highly enriched in the MDS/myeloproliferative syndrome chronic myelomonocytic leukemia (CMML) (Yoshida et al. 2011; Meggendorfer et al. 2012).